These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 11454365

  • 1. Amyloid proteins in pathogenesis of AA amyloidosis.
    Cunnane G.
    Lancet; 2001 Jul 07; 358(9275):4-5. PubMed ID: 11454365
    [No Abstract] [Full Text] [Related]

  • 2. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN.
    Lancet; 2001 Jul 07; 358(9275):24-9. PubMed ID: 11454373
    [Abstract] [Full Text] [Related]

  • 3. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr 07; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL.
    Am J Med; 2006 Apr 07; 119(4):355.e15-24. PubMed ID: 16564782
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB, Madhoo S, Pepys MB, Hawkins PN.
    Gastroenterology; 1997 Apr 07; 112(4):1362-5. PubMed ID: 9098022
    [Abstract] [Full Text] [Related]

  • 6. Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis.
    Noordzij W, Glaudemans AW, van Rheenen RW, Dierckx RA, Slart RH, Hazenberg BP.
    Amyloid; 2014 Jun 07; 21(2):131-3. PubMed ID: 24479618
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 8. New frontiers in the study of amyloidosis.
    Cohen AS, Skinner M.
    N Engl J Med; 1990 Aug 23; 323(8):542-3. PubMed ID: 2377179
    [No Abstract] [Full Text] [Related]

  • 9. [Mapping of amyloidosis by Iodine-123 labelled serum amyloid P component scintigraphy: myth or reality?].
    Hachulla E, Deveaux M, Duquesnoy B, Marchandise X.
    Rev Med Interne; 1994 Apr 23; 15(4):238-9. PubMed ID: 8059142
    [No Abstract] [Full Text] [Related]

  • 10. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB.
    J Exp Med; 1988 Mar 01; 167(3):903-13. PubMed ID: 3351437
    [Abstract] [Full Text] [Related]

  • 11. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component.
    Caspi D, Zalzman S, Baratz M, Teitelbaum Z, Yaron M, Pras M, Baltz ML, Pepys MB.
    Arthritis Rheum; 1987 Nov 01; 30(11):1303-6. PubMed ID: 3689465
    [Abstract] [Full Text] [Related]

  • 12. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands].
    Hachulla E, Wechsler B, Deveaux M, Godeau P, Hatron PY, Devulder B, Janin A, Marchandise X.
    Rev Med Interne; 1994 Mar 01; 15(3):182-5. PubMed ID: 8059132
    [Abstract] [Full Text] [Related]

  • 13. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN.
    Gut; 1998 May 01; 42(5):727-34. PubMed ID: 9659172
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic tools for amyloidosis.
    Hachulla E, Grateau G.
    Joint Bone Spine; 2002 Dec 01; 69(6):538-45. PubMed ID: 12537260
    [Abstract] [Full Text] [Related]

  • 15. Imaging amyloidosis with radiolabelled SAP.
    Hawkins PN, Pepys MB.
    Eur J Nucl Med; 1995 Jul 01; 22(7):595-9. PubMed ID: 7498219
    [No Abstract] [Full Text] [Related]

  • 16. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, Vellenga E, Haagsma EB, Posthumus MD, Jager PL.
    J Nucl Med; 2007 Jun 01; 48(6):865-72. PubMed ID: 17504868
    [Abstract] [Full Text] [Related]

  • 17. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 01; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 18. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.
    Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB.
    QJM; 2002 Apr 01; 95(4):211-8. PubMed ID: 11937647
    [Abstract] [Full Text] [Related]

  • 19. Scintigraphy using iodine 123-labeled serum amyloid P component in ten patients with secondary AA type amyloidosis. A descriptive study.
    Feutrie ML, Hachulla E, Flipo RM, Huglo D, Maulin L, Deveaux M, Duquesnoy B, Delcambre B, Marchandise X.
    Rev Rhum Engl Ed; 1996 Dec 01; 63(11):866-9. PubMed ID: 9010977
    [No Abstract] [Full Text] [Related]

  • 20. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
    Hawkins PN.
    Clin Sci (Lond); 1994 Sep 01; 87(3):289-95. PubMed ID: 7955904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.